AI Article Synopsis

  • The COVID-19 control measures led to significant reductions in PM (particulate matter) concentrations in 20 out of 46 countries, with varying impacts seen between developed and developing nations.
  • The lockdown resulted in a notable decrease in health issues, preventing thousands of deaths and hospital admissions, especially in developing countries, where the economic cost savings from reduced PM-related health burdens were also higher.
  • Disparities in air quality changes were attributed to different chemical compositions of PM, with developing countries experiencing greater reductions due to higher levels of primary PM compared to developed countries, which had more secondary PM processing.

Article Abstract

It is enlightening to determine the discrepancies and potential reasons for the degree of impact from the COVID-19 control measures on air quality as well as the associated health and economic impacts. Analysis of air quality, socio-economic factors, and meteorological data from 447 cities in 46 countries indicated that the COVID-19 control measures had significant impacts on the PM (particulate matter with an aerodynamic diameter less than 2.5 μm) concentrations in 20 (reduced PM concentrations of -7.4-29.1 μg m) of the selected 46 countries. In these 20 countries, the robustly distinguished changes in the PM concentrations caused by the control measures differed between the developed (95% confidence interval (CI): -2.7-5.5 μg m) and developing countries (95% CI: 8.3-23.2 μg m). As a result, the COVID-19 lockdown reduced death and hospital admissions change from the decreased PM concentrations by 7909 and 82,025 cases in the 12 developing countries, and by 78 and 1214 cases in the eight developed countries. The COVID-19 lockdown reduced the economic cost from the PM related health burden by 54.0 million dollars in the 12 developing countries and by 8.3 million dollars in the eight developed countries. The disparity was related to the different chemical compositions of PM. In particular, the concentrations of primary PM (e.g., BC) in cities of developing countries were 3-45 times higher than those in developed countries, so the mass concentration of PM was more sensitive to the reduced local emissions in developing countries during the COVID-19 control period. The mass fractions of secondary PM in developed countries were generally higher than those in developing countries. As a result, these countries were more sensitive to the secondary atmospheric processing that may have been enhanced due to reduced local emissions.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601204PMC
http://dx.doi.org/10.1016/j.envpol.2021.118544DOI Listing

Publication Analysis

Top Keywords

developing countries
28
developed countries
16
countries
15
covid-19 lockdown
12
covid-19 control
12
control measures
12
health economic
8
economic impacts
8
air quality
8
lockdown reduced
8

Similar Publications

No evidence that breast cancer occurs at higher rates among young Arab women.

East Mediterr Health J

December 2024

Department of Radiology, King Abdulaziz University, Jeddah, Saudi Arabia.

Background: Breast cancer is often thought to occur at a younger age among Arab women based on the mean or median age at diagnosis, or the proportion of women diagnosed with breast cancer at a young age.

Objective: To compare age-specific breast cancer incidence rates among women from selected Arab countries with selected high- and middle-income countries.

Methods: We examined population-based, age-specific, national or regional breast cancer incidence data for 2008-2012 and 2013-2017 from Australia, Brazil, Canada, Germany, Japan, United Kingdom, and United States of America, and compared them with data from Algeria, Bahrain, Jordan, Kuwait, Morocco, Qatar, and Saudi Arabia.

View Article and Find Full Text PDF

Atopic dermatitis (AD) is a common inflammatory dermatitis of the skin and poses therapeutic challenges due to the adverse reactions and high costs associated with available treatments. In Eastern Asian countries, a plethora of herbal remedies is extensively employed for the alleviation of AD. Many of these botanicals are renowned for their formidable anti-inflammatory properties, contributing to AD management.

View Article and Find Full Text PDF

Delays in getting injured patients to hospital in a timely manner can increase avoidable death and disability. Like many low- or middle-income countries (LMICs), Rwanda experiences delays related to lack of efficient prehospital communication and formal guidelines to triage patients for hospital care. This paper describes the protocol to develop, roll out, and evaluate the effectiveness of a Destination Decision Support Algorithm (DDSA) integrated in an electronic communication platform, '912Rwanda'.

View Article and Find Full Text PDF

Epstein-Barr virus, vitamin D and the immune response: connections with consequences for multiple sclerosis.

Front Immunol

January 2025

Department of Medical Microbiology and Immunology, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain, United Arab Emirates.

Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) with no definitive trigger. However, epidemiological studies indicate that environmental factors, such as infection with Epstein-Barr virus (EBV) and low vitamin D (Vit D) levels in genetically predisposed individuals, are important risk factors. One leading proposal is that EBV triggers MS via mechanisms such as molecular mimicry, where activated autoreactive B and T lymphocytes mistakenly target self-antigens.

View Article and Find Full Text PDF

On 25-26 April 2024, the 5th PPRI (Pharmaceutical Pricing and Reimbursement Information) Conference on ensuring equitable access to affordable medicines took place in Vienna (Austria). Twenty-four accepted contributions were presented either as oral presentations or posters, adding to invited keynote lectures, stakeholder debates and workshops. The global multi-stakeholder audience discussed a range of approaches in pharmaceutical policies, which have the potential to successfully and sustainably address current and future challenges in ensuring patient access to affordable medicines globally.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!